Literature DB >> 23192489

Atypical serological profiles in hepatitis B virus infection.

Robério A A Pondé1.   

Abstract

During hepatitis B virus (HBV) infection, at least four antigen-antibody systems are observed: HBsAg and anti-HBs; preS antigen and anti-preS antibody; HBcAg and anti-HBc; and HBeAg and anti-HBe. Through the examination of these antigen-antibody systems, hepatitis B infection is diagnosed and the course of the disorder may be observed. Although the serologic findings that allow both the diagnosis of HBV infection as well as assessing of its clinical course are already well established, the dynamics of viral proteins expression and of the antibodies production may vary during the infection natural course. This causes the HBV infection to be occasionally associated with the presence of uncommon serological profiles, which could lead to doubts in the interpretation of results or suspicion of a serological result being incorrect. This paper is dedicated to the discussion of some of these profiles and their significance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23192489     DOI: 10.1007/s10096-012-1781-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  124 in total

Review 1.  Naturally occurring variants of hepatitis B virus.

Authors:  S Günther; L Fischer; I Pult; M Sterneck; H Will
Journal:  Adv Virus Res       Date:  1999       Impact factor: 9.937

2.  Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/l seroprotection levels unreliable.

Authors:  R A Heijtink; P M Schneeberger; B Postma; W Crombach
Journal:  Vaccine       Date:  2002-07-26       Impact factor: 3.641

3.  Heterogeneity of hepatitis B virus (HBV) core gene in a patient with HBV-associated cirrhosis and serum negativity for anti-HBc.

Authors:  F Zoulim; X Zhang; C Pichoud; C Trepo
Journal:  J Hepatol       Date:  1996-02       Impact factor: 25.083

4.  Hepatitis B virus C gene heterogeneity in a familial cluster of anti-HBc negative chronic carriers.

Authors:  G Fiordalisi; D Primi; E Tanzi; E Magni; C Incarbone; A R Zanetti; E Cariani
Journal:  J Med Virol       Date:  1994-02       Impact factor: 2.327

5.  Blood donors infected with the hepatitis B virus but persistently lacking antibodies to the hepatitis B core antigen.

Authors:  S Laperche; C Guitton; W Smilovici; A M Courouce
Journal:  Vox Sang       Date:  2001-02       Impact factor: 2.144

Review 6.  Hepatitis B virus reinfection after liver transplantation: related risk factors and perspective.

Authors:  Li-Ming Wu; Xiao Xu; Shu-Sen Zheng
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2005-11

7.  Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter.

Authors:  Vaishali Chaudhuri; Ruchi Tayal; Baibaswata Nayak; Subrat Kumar Acharya; Subrat Kumar Panda
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 8.  The core promoter of hepatitis B virus.

Authors:  A Kramvis; M C Kew
Journal:  J Viral Hepat       Date:  1999-11       Impact factor: 3.728

9.  Mutations of some critical amino acid residues in the hepatitis B virus surface antigen.

Authors:  S A Bruce; K Murray
Journal:  J Med Virol       Date:  1995-06       Impact factor: 2.327

10.  Hepatitis B core IgM antibody (anti-HBcIgM) among hepatitis B surface antigen (HBsAg) negative blood donors in Nigeria.

Authors:  Margaret Oluwatoyin Japhet; Olufisayo Adeyemi Adesina; Emmanuel Donbraye; Moses Olubusuyi Adewumi
Journal:  Virol J       Date:  2011-11-10       Impact factor: 4.099

View more
  12 in total

Review 1.  Molecular mechanisms underlying HBsAg negativity in occult HBV infection.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-24       Impact factor: 3.267

2.  Hepatitis B Core Antibody Negativity in a Chronic Hepatitis B Infected Patient: Report of an Unusual Serological Pattern.

Authors:  Vijeta Bajpai; Ekta Gupta; Naveen Kundu; Shvetank Sharma; S M Shashtry
Journal:  J Clin Diagn Res       Date:  2017-08-01

Review 3.  Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection: the differential serological diagnosis.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-18       Impact factor: 3.267

4.  Simultaneous electrochemical determination of two hepatitis B antigens using graphene-SnO2 hybridized with sea urchin-like bimetallic nanoparticles.

Authors:  Liping Jiang; Yueyuan Li; Zhen Xu; Xinjin Li; Yueyun Li; Qing Liu; Ping Wang; Yunhui Dong
Journal:  Mikrochim Acta       Date:  2021-03-04       Impact factor: 5.833

5.  Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs.

Authors:  Yong Liu; Le Zhang; Jin-Yong Zhou; Jinshun Pan; Wei Hu; Yi-Hua Zhou
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

6.  Evolution of full-length genomes of HBV quasispecies in sera of patients with a coexistence of HBsAg and anti-HBs antibodies.

Authors:  Tai-Cheng Zhou; Xiao Li; Long Li; Xiao-Fei Li; Liang Zhang; Jia Wei
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

7.  Natural antibody IgG levels are associated with HBeAg-positivity and seroconversion in chronic hepatitis B patients treated with entecavir.

Authors:  Youkyung H Choi; Hyun Woong Lee; Michael A Purdy
Journal:  Sci Rep       Date:  2022-03-14       Impact factor: 4.996

8.  The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing.

Authors:  Ying Wang; Xiao Xiao; Shipeng Chen; Chenjun Huang; Jun Zhou; Erhei Dai; Ya Li; Lijuan Liu; Xianzhang Huang; Zhiyuan Gao; Chuanyong Wu; Meng Fang; Chunfang Gao
Journal:  Front Immunol       Date:  2021-11-25       Impact factor: 7.561

9.  Antibody and immune memory persistence post infant hepatitis B vaccination.

Authors:  Shuaibu A Hudu; Yasmin A Malik; Mohd Taib Niazlin; Nabil S Harmal; Ariza Adnan; Ahmed S Alshrari; Zamberi Sekawi
Journal:  Patient Prefer Adherence       Date:  2013-09-27       Impact factor: 2.711

10.  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Sarah Schillie; Claudia Vellozzi; Arthur Reingold; Aaron Harris; Penina Haber; John W Ward; Noele P Nelson
Journal:  MMWR Recomm Rep       Date:  2018-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.